))
How Biomarkers and Brain Imaging Are Used to Detect Early Stages of Alzheimer’s Disease
Archived series ("HTTP Redirect" status)
Replaced by: Dementia Matters
When?
This feed was archived on January 04, 2018 22:49 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 201918846 series 1746213
Content provided by Wisconsin Alzheimer's Disease Research Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Wisconsin Alzheimer's Disease Research Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Alzheimer's disease-related changes occur in the brain more than 15 years before a person experiences the memory and personality changes associated with the disease. By studying the disease in its earliest stages, scientists hope to find treatments that can prevent or delay the onset of dementia and memory loss. Guest: Sterling Johnson, PhD, Clinical Neuropsychologist, Professor of Geriatrics, University of Wisconsin School of Medicine and Public Health, Associate Director of the Wisconsin Alzheimer's Disease Research Center, Principle Investigator of the Wisconsin Registry for Alzheimer's Prevention (WRAP) Study
20 episodes
Share
